<code id='2333B92ECA'></code><style id='2333B92ECA'></style>
    • <acronym id='2333B92ECA'></acronym>
      <center id='2333B92ECA'><center id='2333B92ECA'><tfoot id='2333B92ECA'></tfoot></center><abbr id='2333B92ECA'><dir id='2333B92ECA'><tfoot id='2333B92ECA'></tfoot><noframes id='2333B92ECA'>

    • <optgroup id='2333B92ECA'><strike id='2333B92ECA'><sup id='2333B92ECA'></sup></strike><code id='2333B92ECA'></code></optgroup>
        1. <b id='2333B92ECA'><label id='2333B92ECA'><select id='2333B92ECA'><dt id='2333B92ECA'><span id='2333B92ECA'></span></dt></select></label></b><u id='2333B92ECA'></u>
          <i id='2333B92ECA'><strike id='2333B92ECA'><tt id='2333B92ECA'><pre id='2333B92ECA'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:44729
          Grail

          Three sales executives, all of them women, have filed suit against Grail, a cancer diagnostics company, alleging that they were harassed, that the company failed to take corrective action, and that it retaliated by removing them from consideration for promotions.

          The suits, which were filed earlier this week, are complicated by the fact that Grail was purchased by Illumina, the largest DNA sequencing firm, for $8 billion in 2021 — yet Illumina has left Grail to operate as a separate company. Illumina is named in the suit.

          advertisement

          All three plaintiffs are being represented by the Vora Law Firm, based in Santa Monica, Calif.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves
          At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

          BristolCEOChristopherBoernerBusinessWireviaAPSANFRANCISCO— ChristopherBoernerhasbeentheCEOofBristolM

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

          InhonorofJPMWeek,you’rereadingaspecialeditionofourbiotechnewsletter,TheReadout.Tostayontopofthelates